Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitors

Autor: Arthur Van Aerschot, L. Pang, Jef Rozenski, Paul Cos, Dries De Ruysscher, Stijn M.G. Lenders, Stephen D. Weeks, Davie Cappoen, Sergei V. Strelkov
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Models
Molecular

Staphylococcus aureus
Antifungal Agents
Triazole
Microbial Sensitivity Tests
Crystallography
X-Ray

01 natural sciences
03 medical and health sciences
chemistry.chemical_compound
Structure-Activity Relationship
Sugar Alcohols
Drug Discovery
Candida albicans
Escherichia coli
Structure–activity relationship
Enzyme Inhibitors
030304 developmental biology
Pharmacology
chemistry.chemical_classification
0303 health sciences
Dose-Response Relationship
Drug

Molecular Structure
010405 organic chemistry
Leucyl-tRNA synthetase
Pharmacology. Therapy
Organic Chemistry
General Medicine
Mycobacterium tuberculosis
Structure-activity relationship
Antimicrobial
Neisseria gonorrhoeae
0104 chemical sciences
Anti-Bacterial Agents
Enzyme inhibition
Enzyme
Biochemistry
chemistry
Leucine-tRNA Ligase
Bi-substrate competitive inhibitors
Leucine
Antibacterial activity
Nucleoside
Protein-ligand co-crystal structures
Zdroj: European journal of medicinal chemistry
ISSN: 0223-5234
Popis: Leucyl-tRNA synthetase (LeuRS) is a clinically validated target for the development of antimicrobials. This enzyme catalyzes the formation of charged tRNALeu molecules, an essential substrate for protein translation. In the first step of catalysis LeuRS activates leucine using ATP, forming a leucyl-adenylate intermediate. Bi-substrate inhibitors that mimic this chemically labile phosphoanhydride-linked nucleoside have proven to be potent inhibitors of different members of the aminoacyl-tRNA synthetase family but, to date, they have demonstrated poor antibacterial activity. We synthesized a small series of 1,5-anhydrohexitol-based analogues coupled to a variety of triazoles and performed detailed structure-activity relationship studies with bacterial LeuRS. In an in vitro assay, Kiapp values in the nanomolar range were demonstrated. Inhibitory activity differences between the compounds revealed that the polarity and size of the triazole substituents affect binding. X-ray crystallographic studies of N. gonorrhoeae LeuRS in complex with all the inhibitors highlighted the crucial interactions defining their relative enzyme inhibitory activities. We further examined their in vitro antimicrobial properties by screening against several bacterial and yeast strains. While only weak antibacterial activity against M. tuberculosis was detected, the extensive structural data which were obtained could make these LeuRS inhibitors a suitable starting point towards further antibiotic development. ispartof: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY vol:211 ispartof: location:France status: published
Databáze: OpenAIRE